Susana Coimbra, Susana Rocha, Cristina Catarino, Maria João Valente, Petronila Rocha-Pereira, Maria Sameiro-Faria, José Gerardo Oliveira, José Madureira, João Carlos Fernandes, Vasco Miranda and 3 more
Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Susana CoimbraUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-8411-8038
Susana RochaUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-4196-2217
Cristina CatarinoUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.
Maria João ValenteNational Food Institute, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.ORCID 0000-0001-6162-2426
Petronila Rocha-PereiraUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.
Maria Sameiro-FariaUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.
José Gerardo OliveiraHemodialysis Clinic of Porto (CHP), 4200-227 Porto, Portugal.
José MadureiraHemodialysis Unit of Barcelos | Nefroserve, 4750-110 Barcelos, Portugal.
João Carlos FernandesHemodialysis Unit of Viana do Castelo | Nefroserve, 4900-281 Viana do Castelo, Portugal.
Vasco MirandaHemodialysis Clinic of Gondomar, 4420-086 Gondomar, Portugal.
Luís BeloUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-3941-6850
Elsa Bronze-da-RochaUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-3571-2513
Alice Santos-SilvaUCIBIO-Applied Molecular Biosciences Unit, Associate Laboratory, Faculdade de Farmácia da Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-2565-3169
We aimed to study the impact of polymorphisms in the genes encoding interleukin-6 (IL6) and tumor necrosis factor receptor-2 (TNFR2), reported to be mortality risk predictors, in patients with end-stage kidney disease (ESKD) undergoing dialysis.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.